Skip to main content
. 2024 May 18;13(10):e034518. doi: 10.1161/JAHA.124.034518

Figure 2. Comparison of cardiac biomarker change among patients with and without composite outcomes.

Figure 2

The frequencies of increase in the levels of high‐sensitivity cardiac troponin T (hs‐cTnT) (A), B‐type natriuretic peptide (BNP) (B), and both hs‐cTnT and BNP (C) during the first year after tafamidis administration were compared between the patients with and without composite outcomes during the follow‐up period.